Director/PDMR and PCA Shareholding
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your AMS notes
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies, announces that it was notified on 28 March 2024 that on the same day Chris Meredith, who is a Director and PDMR, had sold 40,500 Ordinary Shares of 5p held on his behalf held in the name of Platform Securities Nominees Limited ("Nominee"), at a price of 196.15p per Ordinary Share.
On the same day, the Company was also informed that at the same time Individual Savings Accounts ("ISA's") held in the name of Chris Meredith purchased 5,160 Ordinary Shares of 5p, ISA's held in the name of Ingrid Meredith purchased 3,792 Ordinary Shares of 5p, ISA's in the name of Chris Meredith's PCA's purchased 26,472 Ordinary Shares of 5p and that Lifetime Individual Savings Accounts ("LISA's") held in the name of Chris Meredith's PCA's purchased 5,076 Ordinary Shares of 5p, all at a price of 196.2p per Ordinary Share.
The number of shares, and the beneficial ownership of the shares, held by Chris Meredith, Ingrid Meredith and his PCA's remains unchanged. These transactions are part of normalised tax planning.
| 1. | Details of the person discharging managerial responsibilities/person closely associated |
| a) | Name: Chris Meredith |
| 2. | Reason for the notification |
| a) | Position/status: Director |
| b) | Initial notification/Amendment: Initial Notification |
| a) | Name: Advanced Medical Solutions Group plc |
| b) | LEI: 213800HJP6OWOSZI1L74 |
| a) | Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594 |
| b) | Nature of the transactions: · Sale of 5,160 Ordinary Shares of 5p held in the name of the Nominee · Purchase of 5,160 Ordinary Shares of 5p in to ISA's held in the name of Chris Meredith |
| c) | Price(s) and volume(s): Sale of shares: Price(s) Volume(s) Sale of shares from Nominee holding at 196.15p per share 5,160 Purchase by ISA's at 196.2p per share 5,160 |
| d) | Aggregated information: (Relates to those shares sold only) Aggregated volume: 5,160 Aggregated price: 196.15p |
| e) | Date of the transaction: 28/03/2024 |
| f) | Place of the transaction: London Stock Exchange, AIM Market (XLON) |
| 1. | Details of the person discharging managerial responsibilities/person closely associated |
| a) | Name: Chris Meredith |
| 2. | Reason for the notification |
| a) | Position/status: Director |
| b) | Initial notification/Amendment: Initial Notification |
| a) | Name: Advanced Medical Solutions Group plc |
| b) | LEI: 213800HJP6OWOSZI1L74 |
| a) | Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594 |
| b) | Nature of the transactions: · Sale of 3,792 Ordinary Shares of 5p held in the name of the Nominee · Purchase of 3,792 Ordinary Shares of 5p in to ISA's held in the name of Ingrid Meredith |
| c) | Price(s) and volume(s): Sale of shares: Price(s) Volume(s) Sale of shares from Nominee holding at 196.15p per share 3,792 Purchase by ISA's at 196.2p per share 3,792 |
| d) | Aggregated information: (Relates to those shares sold only) Aggregated volume: 3,792 Aggregated price: 196.15p |
| e) | Date of the transaction: 28/03/2024 |
| f) | Place of the transaction: London Stock Exchange, AIM Market (XLON) |
| 1. | Details of the person discharging managerial responsibilities/person closely associated |
| a) | Name: Chris Meredith |
| 2. | Reason for the notification |
| a) | Position/status: Director |
| b) | Initial notification/Amendment: Initial Notification |
| a) | Name: Advanced Medical Solutions Group plc |
| b) | LEI: 213800HJP6OWOSZI1L74 |
| a) | Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594 |
| b) | Nature of the transactions: · Sale of 26,472 Ordinary Shares of 5p held in the name of the Nominee · Purchase of 26,472 Ordinary Shares of 5p in to ISA's held in the name of Chris Meredith's PCA's |
| c) | Price(s) and volume(s): Sale of shares: Price(s) Volume(s) Sale of shares from Nominee holding at 196.15p per share 26,472 Purchase by ISA's at 196.2p per share 26,472 |
| d) | Aggregated information: (Relates to those shares sold only) Aggregated volume: 26,472 Aggregated price: 196.15p |
| e) | Date of the transaction: 28/03/2024 |
| f) | Place of the transaction: London Stock Exchange, AIM Market (XLON) |
| 1. | Details of the person discharging managerial responsibilities/person closely associated |
| a) | Name: Chris Meredith |
| 2. | Reason for the notification |
| a) | Position/status: Director |
| b) | Initial notification/Amendment: Initial Notification |
| a) | Name: Advanced Medical Solutions Group plc |
| b) | LEI: 213800HJP6OWOSZI1L74 |
| a) | Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594 |
| b) | Nature of the transactions: · Sale of 5,076 Ordinary Shares of 5p held in the name of the Nominee · Purchase of 5,076 Ordinary Shares of 5p in to LISA's held in the name of Chris Meredith's PCA's |
| c) | Price(s) and volume(s): Sale of shares: Price(s) Volume(s) Sale of shares from Nominee holding at 196.15p per share 5,076 Purchase by LISA's at 196.2p per share 5,076 |
| d) | Aggregated information: (Relates to those shares sold only) Aggregated volume: 5,076 Aggregated price: 196.15p |
| e) | Date of the transaction: 28/03/2024 |
| f) | Place of the transaction: London Stock Exchange, AIM Market (XLON) |
| ICR Consilium | Tel: +44 (0) 20 3709 5700 |
| Mary-Jane Elliott / Lucy Featherstone | AMS@consilium-comms.com |
| Investec Bank PLC (NOMAD & Broker) | Tel: +44 (0) 20 7597 5970 |
| Gary Clarence / David Anderson | |
| HSBC Bank PLC (Broker) | Tel: 44 (0) 20 7991 8888 |
Sam McLennan / Joe Weaving / Stephanie Cornish
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.